Cigarette Filters
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
I UNITED STATES DISTRICT COURT for the DISTRICT OF
Case 1:99-cv-02496-PLF Document 6276 Filed 08/03/18 Page 1 of 59 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ____________________________________ UNITED STATES OF AMERICA, ) Plaintiff, ) Civil Action No. 99-CV-2496 (PLF) ) and ) ) CAMPAIGN FOR TOBACCO-FREE ) KIDS, et al., ) Plaintiff-Intervenors, ) ) v. ) ) PHILIP MORRIS USA INC., et al., ) Defendants. ) ) and ) ) ITG BRANDS, LLC, et al., ) Post-Judgment Parties ) Regarding Remedies ) PLAINTIFFS’ 2018 SUPPLEMENTAL BRIEF ON RETAIL POINT OF SALE REMEDY TABLE OF CONTENTS TABLE OF AUTHORITIES ......................................................................................................... iv INTRODUCTION .......................................................................................................................... 1 FACTUAL BACKGROUND ......................................................................................................... 5 I. The Deal between Cigarette Manufacturers and Retailers ............................................... 5 II. Benefits to Participating Retailers .................................................................................... 6 III. Manufacturers’ Contractual Control over Space for Cigarette Marketing and Promotional Displays ....................................................................................................... 8 A. The types of retail advertising and marketing space ........................................8 B. The manufacturers’ contractual authority over participating retailers’ space 10 1. The -
PM 12.31.2014 Form 10K Wrap (Incl F/S & MD&A)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33708 PHILIP MORRIS INTERNATIONAL INC. (Exact name of registrant as specified in its charter) Virginia 13-3435103 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 120 Park Avenue, New York, New York 10017 (Address of principal executive offices) (Zip Code) 917-663-2000 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, no par value New York Stock Exchange Floating Rate Notes due 2015 New York Stock Exchange 5.875% Notes due 2015 New York Stock Exchange 2.500% Notes due 2016 New York Stock Exchange 1.625% Notes due 2017 New York Stock Exchange 1.125% Notes due 2017 New York Stock Exchange 1.250% Notes due 2017 New York Stock Exchange 5.650% Notes due 2018 New York Stock Exchange 1.875% Notes due 2019 New York Stock Exchange 2.125% Notes due 2019 New York Stock Exchange 1.750% Notes due 2020 New York Stock Exchange 4.500% Notes due 2020 New York Stock Exchange 1.875% Notes due 2021 New York Stock Exchange 4.125% Notes due 2021 New York Stock Exchange 2.900% Notes due 2021 New York Stock Exchange -
Subject: ACCEPTED FORM TYPE 10-K (0001193125-12-076983) Date: 24-Feb-2012 09:29
Subject: ACCEPTED FORM TYPE 10-K (0001193125-12-076983) Date: 24-Feb-2012 09:29 THE FOLLOWING SUBMISSION HAS BEEN ACCEPTED BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. COMPANY: Philip Morris International Inc. FORM TYPE: 10-K NUMBER OF DOCUMENTS: 17 RECEIVED DATE: 24-Feb-2012 09:28 ACCEPTED DATE: 24-Feb-2012 09:29 FILING DATE: 24-Feb-2012 09:28 TEST FILING: NO CONFIRMING COPY: NO ACCESSION NUMBER: 0001193125-12-076983 FILE NUMBER(S): 1. 001-33708 THE PASSWORD FOR LOGIN CIK 0001193125 WILL EXPIRE 09-Feb-2013 13:14. PLEASE REFER TO THE ACCESSION NUMBER LISTED ABOVE FOR FUTURE INQUIRIES. REGISTRANT(S): 1. CIK: 0001413329 COMPANY: Philip Morris International Inc. ACCELERATED FILER STATUS: LARGE ACCELERATED FILER FORM TYPE: 10-K FILE NUMBER(S): 1. 001-33708 24-Feb-2012 09:29 Page 1 of 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33708 PHILIP MORRIS INTERNATIONAL INC. (Exact name of registrant as specified in its charter) Virginia 13-3435103 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 120 Park Avenue, New York, New York 10017 (Address of principal executive offices) (Zip Code) 917-663-2000 (Registrant’s telephone number, including area code) Securities registered -
Electronic Cigarettes (E-Cigarettes)
Electronic Cigarettes (e-cigarettes) Electronic cigarettes (also called -e cigarettes or electronic nicotine delivery systems) are battery-operated devices designed to deliver nicotine with flavorings and other chemicals to users in vapor instead of smoke. They can be manufactured to resemble traditional tobacco cigarettes, cigars or pipes, or even everyday items like pens or USB memory sticks; newer devices, such as those with fillable tanks, may look different. More than 250 different e-cigarette brands are currently on the market. While e-cigarettes are often promoted as safer alternatives to traditional cigarettes, which deliver nicotine by burning tobacco, little is actually known yet about the health risks of using these devices. How do e-cigarettes work? Electronic cigarettes are Most e-cigarettes consist of three different components, including: battery-operated devices a cartridge, which holds a liquid solution containing varying amounts of designed to deliver nicotine nicotine, flavorings, and other chemicals with flavorings and other a heating device (vaporizer) chemicals to users in vapor a power source (usually a battery) instead of smoke. In many e-cigarettes, puffing activates the battery-powered heating device, Although they do not which vaporizes the liquid in the cartridge. The resulting aerosol or vapor is produce tobacco smoke, then inhaled (called "vaping"). e-cigarettes still contain nicotine and other Are e-cigarettes safer than conventional cigarettes? potentially harmful Unfortunately, this question is difficult to answer because insufficient information chemicals. is available on these new products. Early evidence suggest that Cigarette smoking remains the leading preventable cause of sickness and e-cigarette use may serve as mortality, responsible for over 400,000 deaths in the United States each year. -
Smoking Behavior and the Use of Cigarette Types Among University Student
E-ISSN 2240-0524 Journal of Educational and Social Research Vol 10 No 5 ISSN 2239-978X www.richtmann.org September 2020 . Research Article © 2020 Arisona et.al.. This is an open access article licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) Smoking Behavior and the Use of Cigarette Types Among University Student Amalia Arisona Laili Rahayuwati Ayu Prawesti Habsyah Saparidah Agustina Faculty of Nursing, Universitas Padjadjaran, Indonesia DOI: https://doi.org/10.36941/jesr-2020-0100 Abstract The number of smokers is increasing every year in Indonesia. Cigarettes can cause several health problems and can even cause death. Aside from conventional cigarettes, e-cigarettes and shisha are starting to get the spotlight. The types of cigarettes include conventional cigarettes, electric cigarettes and shisha can cause health problems to both smokers and the people around them. The purpose of this study was to determine smoking behavior and the use of cigarette types in students. This research was quantitative descriptive. The population in this study were students who have smoked either the conventional, electric or shisha. The sampling technique used was accidental sampling with 384 students as the samples. The instrument in this study used a questionnaire that was independently developed by researchers with a total of 14 questions. The results of the data obtained were then analyzed using descriptive analysis presented in the form of a percentage. Based on the results of the study it was found that non-health students (90.6%) were more likely to smoke than health students (9.4%). -
Altria Group, Inc. Annual Report
Altria Group, Inc. 2019 Annual Report an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company an Altria Company Howard A. Willard III Dear Fellow Shareholders Chairman of the Board and CEO Altria delivered solid performance in a dynamic year for the tobacco industry. Our core tobacco businesses delivered outstanding financial performance, and we made significant progress advancing our non-combustible product platform. We believe Altria’s enhanced business platform positions us well for future success. 2019 Highlights n Grew adjusted diluted earnings per share (EPS) by 5.8%, primarily driven by our core tobacco businesses; and types of legal cases pending against it, especially during the fourth n Achieved $600 million in annualized cost savings, exceeding our $575 quarter of the year. Altria recorded two impairment charges of our JUUL million target announced in December 2018; asset in 2019, reducing our investment to $4.2 billion at year-end, down from n Increased our regular quarterly dividend for the 54th time in 50 years $12.8 billion, our 2019 initial investment. JUUL remains the U.S. leader in the and paid shareholders approximately $6.1 billion in dividends; and e-vapor category, and in January 2020 we revised certain terms governing n Repurchased 16.5 million Altria shares for a total cost of $845 million. -
Altria Group, Inc. Annual Report
ananan Altria Altria Altria Company Company Company an Altria Company ananan Altria Altria Altria Company Company Company | Inc. Altria Group, Report 2020 Annual an Altria Company From tobacco company To tobacco harm reduction company ananan Altria Altria Altria Company Company Company an Altria Company ananan Altria Altria Altria Company Company Company an Altria Company Altria Group, Inc. Altria Group, Inc. | 6601 W. Broad Street | Richmond, VA 23230-1723 | altria.com 2020 Annual Report Altria 2020 Annual Report | Andra Design Studio | Tuesday, February 2, 2021 9:00am Altria 2020 Annual Report | Andra Design Studio | Tuesday, February 2, 2021 9:00am Dear Fellow Shareholders March 11, 2021 Altria delivered outstanding results in 2020 and made steady progress toward our 10-Year Vision (Vision) despite the many challenges we faced. Our tobacco businesses were resilient and our employees rose to the challenge together to navigate the COVID-19 pandemic, political and social unrest, and an uncertain economic outlook. Altria’s full-year adjusted diluted earnings per share (EPS) grew 3.6% driven primarily by strong performance of our tobacco businesses, and we increased our dividend for the 55th time in 51 years. Moving Beyond Smoking: Progress Toward Our 10-Year Vision Building on our long history of industry leadership, our Vision is to responsibly lead the transition of adult smokers to a non-combustible future. Altria is Moving Beyond Smoking and leading the way by taking actions to transition millions to potentially less harmful choices — a substantial opportunity for adult tobacco consumers 21+, Altria’s businesses, and society. To achieve our Vision, we are building a deep understanding of evolving adult tobacco consumer preferences, expanding awareness and availability of our non-combustible portfolio, and, when authorized by FDA, educating adult smokers about the benefits of switching to alternative products. -
Temporary Compliance Waiver Notice the Linked Files May Not Be Fully Accessible to Readers Using Assistive Technology
Temporary Compliance Waiver Notice The linked files may not be fully accessible to readers using assistive technology. We regret any inconvenience that this may cause our readers. In the event you are unable to read the documents or portions thereof, please email [email protected] or call 1-877-287-1373. Philip Morris Products S.A. THS Page 1 PMI Research & Development 2.7 Executive Summary MRTPA Section 2.7 Executive Summary Confidentiality Statement Confidentiality Statement: Data and information contained in this document are considered to constitute trade secrets and confidential commercial information, and the legal protections provided to such trade secrets and confidential information are hereby claimed under the applicable provisions of United States law. No part of this document may be publicly disclosed without the written consent of Philip Morris International. Philip Morris Products S.A. THS Page 2 PMI Research & Development 2.7 Executive Summary TABLE OF CONTENTS 2.7.1 EXECUTIVE SUMMARY .....................................................................................9 2.7.2 PROPOSED MODIFIED RISK AND MODIFIED EXPOSURE CLAIMS ........15 2.7.3 MODIFIED RISK TOBACCO PRODUCTS AND HARM REDUCTION .........17 2.7.4 PRODUCT DESCRIPTION AND SCIENTIFIC RATIONALE ..........................19 Development Rationale and Product Description for THS ............................................19 Heating Instead of Burning Reduces Harmful Constituents ......................................19 Product Description ...................................................................................................20 -
Cigarette Smoking-Induced Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Approaches
Cigarette Smoking-Induced Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Approaches DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Tamer M. Abdelghany Graduate Program in Molecular, Cellular and Developmental Biology The Ohio State University 2013 Dissertation Committee: Dr. Jay L. Zweier, MD, Advisor Dr. Arthur Strauch III, PhD Dr. Amal Amer, MD PhD Copyright by Tamer M. Abdelghany 2013 Abstract Cigarette smoking (CS) remains the single largest preventable cause of death. Worldwide, smoking causes more than five million deaths annually and, according to the current trends, smoking may cause up to 10 million annual deaths by 2030. In the U.S. alone, approximately half a million adults die from smoking-related illnesses each year which represents ~ 19% of all deaths in the U.S., and among them 50,000 are killed due to exposure to secondhand smoke (SHS). Smoking is a major risk factor for cardiovascular disease (CVD). The crucial event of The CVD is the endothelial dysfunction (ED). Despite of the vast number of studies conducted to address this significant health problem, the exact mechanism by which CS induces ED is not fully understood. The ultimate goal of this thesis; therefore, is to study the mechanisms by which CS induces ED, aiming at the development of new therapeutic strategies that can be used in protection and/or reversal of CS-induced ED. In the first part of this study, we developed a well-characterized animal model for chronic secondhand smoke exposure (SHSE) to study the onset and severity of the disease. -
Complete Annual Report
Philip Morris International 2016 Annual Report THIS CHANGES EVERYTHING 2016 Philip Morris Annual Report_LCC/ANC Review Copy February 22 - Layout 2 We’ve built the world’s most successful cigarette company with the world’s most popular and iconic brands. Now we’ve made a dramatic decision. We’ve started building PMI’s future on breakthrough smoke-free products that are a much better choice than cigarette smoking. We’re investing to make these products the Philip Morris icons of the future. In these changing times, we’ve set a new course for the company. We’re going to lead a full-scale effort to ensure that smoke- free products replace cigarettes to the benefit of adult smokers, society, our company and our shareholders. Reduced-Risk Products - Our Product Platforms Heated Tobacco Products Products Without Tobacco Platform Platform 1 3 IQOS, using the consumables Platform 3 is based on HeatSticks or HEETS, acquired technology that features an electronic holder uses a chemical process to that heats tobacco rather Platform create a nicotine-containing than burning it, thereby 2 vapor. We are exploring two Platform creating a nicotine-containing routes for this platform: one 4 vapor with significantly fewer TEEPS uses a pressed with electronics and one harmful toxicants compared to carbon heat source that, once without. A city launch of the Products under this platform cigarette smoke. ignited, heats the tobacco product is planned in 2017. are e-vapor products – without burning it, to generate battery-powered devices a nicotine-containing vapor that produce an aerosol by with a reduction in harmful vaporizing a nicotine solution. -
Indianapolis Air Monitoring Study
INDIANAPOLIS, INDIANA INDOOR AIR QUALITY MONITORING STUDY Mark J. Travers, PhD, MS Lisa Vogl, MPH Department of Health Behavior and Aerosol Pollution Exposure Research Laboratory (APERL) December 2012 EXECUTIVE SUMMARY In May, August and November 2012, indoor air quality was assessed in 10 restaurants and bars in Indianapolis, Indiana. Effective June 1st, 2012, the new Indianapolis law prohibits smoking in most public places and places of employment with exemptions for nonprofit clubs, retail tobacco shops and a horse race betting parlor. Prior to the smoke-free air law, all 10 bar and restaurant locations permitted indoor smoking. After the smoke-free air law took effect all bars and restaurants were reassessed to observe the effect of the new smoke-free air law; no smoking was observed in 7 locations, while 3 locations met requirements to be exempt from the smoke-free air law. The concentration of fine particle air pollution, PM2.5, was measured with a TSI SidePak AM510 Personal Aerosol Monitor. PM2.5 is particulate matter in the air smaller than 2.5 microns in diameter. Particles of this size are released in significant amounts from burning cigarettes, are easily inhaled deep into the lungs, and cause a variety of adverse health effects including cardiovascular and respiratory morbidity and death. Key findings of the study include: In all 10 locations with observed indoor smoking before the law, the level of fine particle air pollution 3 was “very unhealthy” (PM2.5 = 229 µg/m ). In the 7 locations that went smoke-free after the law, the 3 level of fine particle air pollutions was “hazardous” prior to the law (PM2.5 = 273 µg/m ). -
The Filter Fraud: Debunking the Myth of “Safer” As a Key New Strategy Of
THE FILTER FRAUD: DEBUNKING THE MYTH OF “SAFER” AS A KEY NEW STRATEGY OF TOBACCO CONTROL Alan Blum, MD, University of Alabama Center for the Study of Tobacco and Society, Tuscaloosa, AL, USA ([email protected]) Thomas E. Novotny, MD MPH, San Diego State University, Cigarette Butt Pollution Project, San Diego, CA, USA ([email protected]) Background Filters are a Health Hazard Although efforts have been made to eliminate the use of misleading • As with flavorings such as menthol, filters facilitate nicotine descriptors such as “low tar,” “lights,” and “mild” from cigarette addiction by making smoking less harsh and thus easier for marketing, the elimination of the cigarette filter, which is on 99.7% youth to start smoking. For existing smokers, the tobacco of cigarettes sold in United States, has been largely overlooked as a industry fostered consumer complacency and false security tobacco control strategy. The 2014 U.S. Surgeon General’s Report on about the implied protection that the filter could confer, the Health Consequences of Smoking and the 2001 U.S. National diminishing the urgency to quit smoking. Cancer Institute Monograph 13 report that the near-universal • Lung cancer risks among smokers have doubled for men and adoption by smokers of filtered cigarettes since their introduction in increased by almost 10 times for women from 1960-1980; the 1930s has not reduced these consumers’ risks for cancer and relative risks for and incidence of the more aggressive other diseases (1). Moreover, the non-biodegradable filter is the adenocarcinoma increased from 4.6 to19.0 among men and from main component of tobacco product waste in the environment.